Antibody with two targets may boost immunotherapy benefit.
D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000556:secondary / Q000628:therapy*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000556:secondary / Q000628:therapy*
D018033:Antibodies, Bispecific